These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20882049)

  • 1. Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia.
    Lee S; Chung NG; Cho BS; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Kim CC
    Leukemia; 2010 Dec; 24(12):2110-9. PubMed ID: 20882049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Nishiwaki S; Miyamura K; Ohashi K; Kurokawa M; Taniguchi S; Fukuda T; Ikegame K; Takahashi S; Mori T; Imai K; Iida H; Hidaka M; Sakamaki H; Morishima Y; Kato K; Suzuki R; Tanaka J;
    Ann Oncol; 2013 Jun; 24(6):1594-602. PubMed ID: 23372050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source.
    Ferrá C; Sanz J; de la Cámara R; Sanz G; Bermúdez A; Valcárcel D; Rovira M; Serrano D; Caballero D; Espigado I; Morgades M; Heras I; Solano C; Duarte R; Barrenetxea C; García-Noblejas A; Díez-Martin JL; Iriondo A; Carreras E; Sierra J; Sanz MA; Ribera JM;
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):957-66. PubMed ID: 20144909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience.
    Hallböök H; Hägglund H; Stockelberg D; Nilsson PG; Karlsson K; Björkholm M; Linderholm M; Wahlin A; Linder O; Smedmyr B;
    Bone Marrow Transplant; 2005 Jun; 35(12):1141-8. PubMed ID: 15834433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
    J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior transplantation outcomes of 8/8-matched unrelated donors as well as matched siblings to autologous transplantation for acute myeloid leukemia with intermediate cytogenetics in first remission.
    Cho BS; Kim JH; Yoon JH; Shin SH; Yahng SA; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Kim HJ
    Eur J Haematol; 2013 May; 90(5):365-74. PubMed ID: 23414524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups.
    Mo XD; Xu LP; Zhang XH; Liu DH; Wang Y; Chen H; Yan CH; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Int J Cancer; 2015 Apr; 136(7):1697-707. PubMed ID: 25138425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types.
    Yoon JH; Kim HJ; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Oncotarget; 2017 Jun; 8(25):41590-41604. PubMed ID: 28206975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
    Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study.
    Cho BS; Lee S; Kim YJ; Chung NG; Eom KS; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Kim CC
    Leukemia; 2009 Oct; 23(10):1763-70. PubMed ID: 19440217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-intensive therapy for adult acute lymphoblastic leukemia.
    Finiewicz KJ; Larson RA
    Semin Oncol; 1999 Feb; 26(1):6-20. PubMed ID: 10073558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial.
    Thomas X; Boiron JM; Huguet F; Dombret H; Bradstock K; Vey N; Kovacsovics T; Delannoy A; Fegueux N; Fenaux P; Stamatoullas A; Vernant JP; Tournilhac O; Buzyn A; Reman O; Charrin C; Boucheix C; Gabert J; Lhéritier V; Fiere D
    J Clin Oncol; 2004 Oct; 22(20):4075-86. PubMed ID: 15353542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.
    Tomblyn MB; Arora M; Baker KS; Blazar BR; Brunstein CG; Burns LJ; DeFor TE; Dusenbery KE; Kaufman DS; Kersey JH; MacMillan ML; McGlave PB; Miller JS; Orchard PJ; Slungaard A; Tomblyn MR; Vercellotti GM; Verneris MR; Wagner JE; Weisdorf DJ
    J Clin Oncol; 2009 Aug; 27(22):3634-41. PubMed ID: 19581540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
    Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
    Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease.
    Yanada M; Naoe T; Iida H; Sakamaki H; Sakura T; Kanamori H; Kodera Y; Okamoto S; Kanda Y; Sao H; Asai O; Nakai K; Maruta A; Kishi K; Furukawa T; Atsuta Y; Yamamoto K; Tanaka J; Takahashi S
    Bone Marrow Transplant; 2005 Nov; 36(10):867-72. PubMed ID: 16113659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.
    Segal E; Martens M; Wang HL; Brazauskas R; Weisdorf D; Sandmaier BM; Khoury HJ; de Lima M; Saber W
    Cancer; 2017 Sep; 123(17):3346-3355. PubMed ID: 28452054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloablative unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: comparison with other graft sources from related and unrelated donors.
    Konuma T; Kato S; Ooi J; Oiwa-Monna M; Tojo A; Takahashi S
    Ann Hematol; 2015 Feb; 94(2):289-96. PubMed ID: 25178518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes.
    Weisdorf D; Bishop M; Dharan B; Bolwell B; Cahn JY; Cairo M; Giralt S; Klein J; Lazarus H; Litzow M; Marks D; McCarthy P; Miller C; Milone G; Russell J; Schultz KR; Sierra J; Wiernik P; Keating A; Loberiza F; Kollman C; Horowitz M
    Biol Blood Marrow Transplant; 2002; 8(4):213-20. PubMed ID: 12014810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.